Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Joaquin Martínez López"'
Autor:
Juan Eduardo Megias-Vericat, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González, Jaime Pérez de Oteyza, Susana Vives, Belen Vidriales, Pilar Herrera, Juan Antonio Vera, Aurelio López Martínez, Adolfo De la Fuente, María Lourdes Amador, José Ángel Hernández-Rivas, María Ángeles Fernández, Carlos Javier Cerveró, Daniel Morillo, Pilar Hernández Campo, Julián Gorrochategui, Daniel Primo, José Luis Rojas, Margarita Guenova, Joan Ballesteros, Miguel Ángel Sanz, Pau Montesinos
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1, Pp e2019016-e2019016 (2019)
BACKGROUND: Induction schedules in acute myeloid leukemia (AML) are based on combinations of cytarabine and anthracyclines. The choice of the anthracycline employed has been widely studied in multiple clinical trials showing similar complete remissio
Externí odkaz:
https://doaj.org/article/81b4fa5b2a224f32948fabdc5eced125
Autor:
Ignacio Cardona-Benavides, IRENA Misiewicz-Krzeminska, Elizabeta A. Rojas, Cristina de Ramón, Antonio Sanz-Solas, Isabel Isidro, Dalia Quwaider, Aida López-Guerrero, Myriam Cuadrado, Maria José Calasanz, Laura Rosiñol, Joaquin Martínez-López, Jesus San Miguel, Maria Victoria Mateos Manteca, Luis Antonio Corchete, NORMA GUTIERREZ
Upregulation of a cyclin D gene determined by expression microarrays is an almost universal event in MM, but this finding has not been properly confirmed at the protein level. For this reason, we carried out a quantitative analysis of cyclin D protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::549e8bb419d792d7932cc426882f48ce
https://doi.org/10.21203/rs.3.rs-2616507/v1
https://doi.org/10.21203/rs.3.rs-2616507/v1
Autor:
María Teresa Gómez-Casares, Juan Carlos Hernández-Boluda, Antonio Jiménez-Velasco, Joaquin Martínez-López, María Giovanna Ferrario, Irmina Gozalbo, Joana Gostkorzewicz, Rudi Subirá
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 5, Iss 2 (2017)
**Introduction:** Primary myelofibrosis (MF) is a rare hematologic disease belonging to the group of Philadelphia-negative chronic myeloproliferative neoplasms. Identification of the Janus Kinase (JAK) gene mutations inaugurated a new era in the targ
Externí odkaz:
https://doaj.org/article/1081428271f1429e834f40fea1d7798b
Autor:
Catia Simoes, Maria-Carmen Chillon, David Martínez-Cuadrón, Maria-José Calasanz, María-Belén Vridiales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Paula Aguirre-Ruiz, Leire Burgos, Diego Alignani, Sarai Sarvide, Sara Villar, Ana Alfonso Pierola, Felipe Prosper, Rosa Ayala, Joaquin Martínez-López, Juan Miguel Bergua Burgues, Susana Vives, Jose A. Perez-Simon, Maria Garcia-Fortes, Teresa Bernal del Castillo, Mercedes Colorado, Mayte Olave, Juan I. Rodríguez-Gutiérrez, Jorge Labrador, Marcos González, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos, Bruno Paiva
Publikováno v:
Blood Advances
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood advances, 2023, 7(1), 167-173
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood advances, 2023, 7(1), 167-173
Clonal evolution in acute myeloid leukemia (AML) originates long before diagnosis and is a dynamic process that may affect survival. However, it remains uninvestigated during routine diagnostic workup. We hypothesized that the mutational status of bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0ebb29de33b779945272eff40de879e
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=17131
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=17131
Autor:
Gilles Salles, Stephen J. Schuster, Martin Dreyling, Luca Fischer, John Kuruvilla, Piers E. M. Patten, Bastian von Tresckow, Sonali M. Smith, Ana Jiménez-Ubieto, Keith L. Davis, Carla Anjos, Jufen Chu, Jie Zhang, Chiara Lobetti Bodoni, Catherine Thieblemont, Nathan H. Fowler, Michael Dickinson, Joaquin Martínez-López, Yucai Wang, Brian K. Link
The ELARA trial indicates tisagenlecleucel (tisa-cel) is an effective anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory follicular lymphoma (r/r FL). As ELARA is a single-arm trial, this study compares tisa-cel outcomes fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b32044a71d711af56fdd85baf190a3
https://www.ncbi.nlm.nih.gov/pubmed/35973192
https://www.ncbi.nlm.nih.gov/pubmed/35973192
Autor:
Maria-Victoria Mateos, Joaquin Martínez-López, Paula Rodriguez Otero, Enrique M. Ocio, Marta Sonia Gonzalez, Albert Oriol, Norma C. Gutierrez, Bruno Paiva, Rafael Rios, Laura Rosinol, Miguel Angel Alvarez, Maria Jose Calasanz, Joan Bargay, Ana Pilar Gonzalez, Adrián Alegre, Fernando Escalante, Rafael Martínez, Noemi Puig, Javier De La Rubia, Ana Isabel Teruel, María Teresa Cedena, Felipe De Arriba, Luis Palomera, Miguel T Hernández, Javier Lopez Jimenez, Jesús Martín, Esther Piensa, Aránzazu García Mateo, Veronica Gonzalez De La Calle, Joan Bladé, Juan Jose Lahuerta, Jesus F San-Miguel
Publikováno v:
Blood. 132:2142-2142
Introduction:SMM is an asymptomatic and heterogeneous plasma cell disorder. The Spanish Myeloma Group demonstrated that patients at high risk of progression benefit from early treatment with Rd. In addition, our preliminary results of the curative ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebb94926b6b12f5cce95d92bacf18263
https://doi.org/10.1182/blood-2018-99-112656
https://doi.org/10.1182/blood-2018-99-112656
Autor:
M. Teresa Cedena, Inmaculada Rapado, Alejandro Santos-Lozano, Rosa Ayala, Esther Onecha, María Abaigar, Esperanza Such, Fernando Ramos, José Cervera, María Díez-Campelo, Guillermo Sanz, Jesús Hernández Rivas, Alejandro Lucía, Joaquin Martínez-López
Publikováno v:
Oncotarget
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
We evaluated the association of mutations in 34 candidate genes and response to azacitidine in 84 patients with myelodysplastic syndrome (MDS), with 217 somatic mutations identified by next-generation sequencing. Most patients (93%) had ≥1 mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb2acf01bf73d4d0b15910fa0031b52
https://doi.org/10.18632/oncotarget.25856
https://doi.org/10.18632/oncotarget.25856
Autor:
Joaquin Martínez-López, Ana Rivero, Inmaculada Rapado, Carlos Montalbán, Jose Paz-Carreira, Miguel Canales, Rafael Martínez, Pedro Sánchez-Godoy, Alberto Fernández de Sevilla, Francisco J. Peñalver, Marcos Gonzalez, Elena Prieto, Antonio Salar, Carmen Burgaleta, Jose A. Queizán, Maria J. Peñarrubia, Maria D. Monteagudo, Carmen Cabrera, Javier De la Serna, José F. Tomás
Publikováno v:
Leukemia & Lymphoma. 50:1283-1289
The employment of current treatments based on chemotherapy and immunotherapy leads to inmunosuppression. The presence of mutations or polymorphisms in genes related to immune system might involve an additional disadvantage. The aim of the present stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862bcacb6a3c39aee0dfe21e0d568978
https://doi.org/10.1080/10428190903040006
https://doi.org/10.1080/10428190903040006
Autor:
Adrian Mosquera Orgueira, Marta Sonia González Pérez, Jose Diaz Arias, Laura Rosiñol, Albert Oriol, Ana Isabel Teruel, Joaquin Martinez Lopez, Luis Palomera, Miguel Granell, Maria Jesus Blanchard, Javier de la Rubia, Ana López de la Guia, Rafael Rios, Anna Sureda, Miguel Teodoro Hernandez, Enrique Bengoechea, María José Calasanz, Norma Gutierrez, Maria Luis Martin, Joan Blade, Juan-Jose Lahuerta, Jesús San Miguel, Maria Victoria Mateos, the PETHEMA/GEM Cooperative Group
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-9 (2022)
Abstract The International Staging System (ISS) and the Revised International Staging System (R-ISS) are commonly used prognostic scores in multiple myeloma (MM). These methods have significant gaps, particularly among intermediate-risk groups. The a
Externí odkaz:
https://doaj.org/article/cddc86ce994b44c6bfb5da1a17d16eaf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.